Basic Information
| LncRNA/CircRNA Name | SNHG20 |
| Synonyms | SNHG20, C17orf86, LINC00338, NCRNA00338, SCARNA16HG |
| Region | GRCh38_17:77086716-77094990 |
| Ensemble | ENSG00000234912 |
| Refseq | NR_027058 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR, RNAi etc. |
| Sample | HCC tissues, cell lines (HL-7702, MHCC-97H, HepG2, SK-Hep-1, SMMC-7721 etc.) |
| Expression Pattern | up-regulated |
| Function Description | Our results showed that the expression of SNHG20 was remarkably up-regulated in HCC tissues compared with adjacent non-tumor liver tissues from 49 fresh HCC samples (cohort 1) detected by quantitative reverse-transcription polymerase chain reaction. |
| Pubmed ID | 27053960 |
| Year | 2016 |
| Title | Up-regulation of LncRNA SNHG20 Predicts Poor Prognosis in Hepatocellular Carcinoma |
External Links
| Links for SNHG20 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |